Meckler Jeffrey A bought INDP
July 27, 2025 · Form 4 insider transaction
Meckler Jeffrey A bought 12,136 shares of Indaptus Therapeutics, Inc. at $8.30 per share, a transaction worth $100.8K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
The Reporting Person acquired 6,068 shares of common stock and 12,136 warrants to purchase common stock from the Issuer following the mandatory conversion of a convertible note that the Reporting Person acquired from the Issuer in a private placement in June 2025 at a conversion price of $8.3024, which is equal to 80% of the average closing price of the Issuer's shares of common stock on the Nasdaq Capital Market for the five trading days immediately preceding and including the conversion date of July 27, 2025.